Structures by: Sowa M.
Total: 13
C15H10O6,C6H6N2O
C15H10O6,C6H6N2O
CrystEngComm (2013) 15, 38 7696
a=8.945(3)Å b=10.170(3)Å c=11.149(3)Å
α=111.26(3)° β=100.11(3)° γ=97.47(3)°
C15H10O6,C6H6N2O
C15H10O6,C6H6N2O
CrystEngComm (2013) 15, 38 7696
a=8.747(3)Å b=10.231(3)Å c=10.915(3)Å
α=110.96(3)° β=98.49(3)° γ=98.00(3)°
C15H10O5,C6H6N2O,H2O
C15H10O5,C6H6N2O,H2O
CrystEngComm (2013) 15, 38 7696
a=3.780(2)Å b=41.196(10)Å c=11.650(4)Å
α=90.00° β=92.69(3)° γ=90.00°
C15H10O5,C6H6N2O,H2O
C15H10O5,C6H6N2O,H2O
CrystEngComm (2013) 15, 38 7696
a=3.706(2)Å b=41.150(10)Å c=11.564(4)Å
α=90.00° β=92.44(3)° γ=90.00°
C15H10O6,C6H6N2O
C15H10O6,C6H6N2O
CrystEngComm (2013) 15, 38 7696
a=4.278(2)Å b=12.561(4)Å c=17.370(6)Å
α=94.86(3)° β=92.76(3)° γ=99.14(3)°
C15H10O6,C6H6N2O
C15H10O6,C6H6N2O
CrystEngComm (2013) 15, 38 7696
a=4.265(2)Å b=12.485(4)Å c=17.030(6)Å
α=94.22(3)° β=91.27(3)° γ=100.04(3)°
C15H10O6,C6H6N2O
C15H10O6,C6H6N2O
CrystEngComm (2013) 15, 38 7696
a=7.479(3)Å b=8.702(3)Å c=14.642(4)Å
α=104.49(3)° β=92.07(3)° γ=105.20(3)°
C15H10O6,2(C6H6N2O),0.5(C2H6O)
C15H10O6,2(C6H6N2O),0.5(C2H6O)
CrystEngComm (2013) 15, 38 7696
a=7.629(2)Å b=33.472(9)Å c=10.073(3)Å
α=90° β=98.39(3)° γ=90°
C15H10O6,2(C6H6N2O),0.5(C2H6O)
C15H10O6,2(C6H6N2O),0.5(C2H6O)
CrystEngComm (2013) 15, 38 7696
a=7.449(2)Å b=33.320(8)Å c=10.028(3)Å
α=90° β=97.88(3)° γ=90°
C15H10O6,C6H6N2O
C15H10O6,C6H6N2O
CrystEngComm (2014) 16, 46 10592
a=8.204(3)Å b=12.534(3)Å c=18.020(5)Å
α=90° β=102.77(3)° γ=90°
C15H10O6,2(C8H10N4O2)
C15H10O6,2(C8H10N4O2)
CrystEngComm (2014) 16, 46 10592
a=7.553(2)Å b=14.247(5)Å c=15.149(5)Å
α=66.25(4)° β=79.39(3)° γ=81.05(3)°
Baicalein--nicotinamide (1/1)
C6H6N2,C15H10O5
Acta Crystallographica Section C (2012) 68, 7 o262-o265
a=5.248(2)Å b=11.422(3)Å c=14.952(4)Å
α=84.38(3)° β=82.29(3)° γ=79.83(3)°
5,7-Dihydroxy-3-(4-hydroxyphenyl)chromen-4-one--pyridine-4-carboxamide (1/2)
C15H10O5,2(C6H6N2O)
Acta Crystallographica Section C (2013) 69, 11 1267-1272
a=8.233(3)Å b=11.872(4)Å c=13.773(4)Å
α=109.61(3)° β=95.34(3)° γ=109.75(3)°